HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
(S)-morpholine-3-carboxylic acid → (S)-4-[(R)-6-(2-Bromo-4-fluoro-phenyl)-5-methoxycarbonyl-2-(5-methyl-oxazol-4-yl)-3,6-dihydro-pyrimidin-4-ylmethyl]-morpholine-3-carboxylic acid
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | (S)-morpholine-3-carboxylic acid | HCID 1501894 | — |
| Edukt | 2-Bromo-4-fluorobenzaldehyde | HCID 2773319 | — |
| Edukt | 2-Thiazolecarboximidamide | HCID 10887911 | — |
| Edukt | 4,4-Difluoroproline | HCID 15216102 | — |
| Edukt | 5-Methyl-oxazole-4-carboxamidine | HCID 83677387 | — |
| Produkt | (S)-4-[(R)-6-(2-Bromo-4-fluoro-phenyl)-5-methoxycarbonyl-2-(5-methyl-oxazol-4-yl)-3,6-dihydro-pyrimidin-4-ylmethyl]-morpholine-3-carboxylic acid | HCID 73330682 | — |
Reaktionsschritte
The title compound was prepared in analogy to Example 2 with Procedure A shown in Scheme 4 by using 2-bromo-4-fluorobenzaldehyde, 5-methyl-oxazole-4-carboxamidine (Compound AB) and (S)-morpholine-3-carboxylic acid instead of 2-chloro-4-fluorobenzaldehyde, thiazole-2-carboxamidine and (S)-4,4-difluoro-pyrrolidine-2-carboxylic acid. The stereochemistry of Example 65 was determined by comparing its 1H NMR data and HPLC retention time with Example 2.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US09447086B2 |
| Quelldatensatz | uspto-grants-2016_09 |
| ORD ID | ord-78fd8d9d13bb43169e879aecd66398a0 |
| Quellennotiz | uspto-grants-2016_09 |